Search
Searching Goglides
Loading matching companies, research, topics, and discussions.
Searching Goglides
Loading matching companies, research, topics, and discussions.
Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Showing public results only.
Allied still has HyperX Arena Las Vegas, Z-Tech mobile games, and a balance-sheet cushion, but the current thesis is about the late 10-K, Nasdaq delisting risk, reverse-split vote, Knighted settlement, and whether revenue can ever catch the cost base.
Signed-in searches appear here after you use search.
Tag facets appear after tag usage counts are rebuilt.
Palantir just delivered the kind of quarter that makes the bull case difficult to ignore. Q2 revenue reached **$1.94 billion**, up 93% year over year. U.S. commercial revenue jumped 149%, while U.S. government revenue grew 90%. Palantir also raised its full-ye
OpenSEC filings, financial facts, source resources, and Goglides workspace context for Palantir Technologies Inc..
OpenPalantir's index-inclusion narrative can attract attention, but institutional flow only matters if business fundamentals keep confirming the story.
OpenPalantir is a profitable AI software company, but government contract quality matters more than headlines.
OpenPalantir reported FY2025 revenue of $4.5 billion and Q1 2026 revenue of $1.6 billion. The thesis depends on government durability, commercial AI adoption, operating leverage, customer concentration and cash conversion.
OpenElectronic Arts reported FY2026 revenue of $7.5 billion, operating income of $1.2 billion and operating cash flow of $2.6 billion. The thesis depends on sports franchises, live services, player engagement, new game execution and disciplined content investment.
OpenAgomAb Therapeutics is a newly public clinical-stage fibrosis biotech with no revenue, a Nasdaq ADS listing, an IPO-funded runway into the first half of 2029, and two 2026 data tracks that need to validate organ-restricted ALK5 inhibition.
OpenTag facets appear after tag usage counts are rebuilt.